Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.

Holloman JP, Ho CC, Hukki A, Huntley JL, Gallicano GI.

Am J Stem Cells. 2013 Jun 30;2(2):95-107. Print 2013.

2.

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, La Nasa G, Musso M, Papineschi F, Rowe JM, Saccardi R, Steck A, Kappos L, Gratwohl A, Tyndall A, Samijn J; Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation).

J Neurol. 2002 Aug;249(8):1088-97. Erratum in: J Neurol. 2002 Nov;249(11):1619.. Samign, J [corrected to Samijn, J]. J Neurol. 2002 Oct;249(10):1482..

PMID:
12195460
3.

Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of action.

Van Wijmeersch B, Sprangers B, Dubois B, Waer M, Billiau AD.

J Neuroimmunol. 2008 Jul 15;197(2):89-98. doi: 10.1016/j.jneuroim.2008.04.030. Epub 2008 Jun 9. Review.

PMID:
18541311
4.

Hematopoietic stem cell transplantation in multiple sclerosis.

Karussis D, Petrou P, Vourka-Karussis U, Kassis I.

Expert Rev Neurother. 2013 May;13(5):567-78. doi: 10.1586/ern.13.36. Review.

PMID:
23621313
5.

High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis.

Shevchenko YL, Novik AA, Kuznetsov AN, Afanasiev BV, Lisukov IA, Kozlov VA, Rykavicin OA, Ionova TI, Melnichenko VY, Fedorenko DA, Kulagin AD, Shamanski SV, Ivanov RA, Gorodokin G.

Exp Hematol. 2008 Aug;36(8):922-8. doi: 10.1016/j.exphem.2008.03.001. Epub 2008 May 12.

PMID:
18468768
6.

Immuno-therapeutic potential of haematopoietic and mesenchymal stem cell transplantation in MS.

Muraro PA, Uccelli A.

Results Probl Cell Differ. 2010;51:237-57. doi: 10.1007/400_2008_14. Review.

PMID:
19513637
7.

Autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.

Loh YS, Hwang WY, Ratnagopal P.

Ann Acad Med Singapore. 2007 Jun;36(6):421-6. Review.

8.

Hematopoietic stem cell transplantation in multiple sclerosis.

Rogojan C, Frederiksen JL.

Acta Neurol Scand. 2009 Dec;120(6):371-82. doi: 10.1111/j.1600-0404.2009.01168.x. Epub 2009 Sep 24. Review.

PMID:
19785643
9.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
10.

Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis.

Shevchenko JL, Kuznetsov AN, Ionova TI, Melnichenko VY, Fedorenko DA, Kartashov AV, Kurbatova KA, Gorodokin GI, Novik AA.

Exp Hematol. 2012 Nov;40(11):892-8. doi: 10.1016/j.exphem.2012.07.003. Epub 2012 Jul 4.

PMID:
22771495
11.

Stem cell transplantation for multiple sclerosis: what is the evidence?

Fassas A, Kimiskidis VK.

Blood Rev. 2003 Dec;17(4):233-40. Review.

PMID:
14556778
12.
13.

Extracorporeal photophoresis: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(6):1-82. Epub 2006 Mar 1.

14.

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.

Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, Scolding N, Slavin S, Le Blanc K, Uccelli A; MSCT Study Group.

Mult Scler. 2010 Apr;16(4):503-10. doi: 10.1177/1352458509359727. Epub 2010 Jan 19.

PMID:
20086020
15.

Hematopoietic stem cell transplantation for multiple sclerosis: current status and future challenges.

Muraro PA, Cassiani Ingoni R, Martin R.

Curr Opin Neurol. 2003 Jun;16(3):299-305. Review.

PMID:
12858065
16.

Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores.

Burt RK, Cohen BA, Russell E, Spero K, Joshi A, Oyama Y, Karpus WJ, Luo K, Jovanovic B, Traynor A, Karlin K, Stefoski D, Burns WH.

Blood. 2003 Oct 1;102(7):2373-8. Epub 2003 Jul 3.

17.

Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis.

Pandit AK, Prasad K, Seth T.

Ann Indian Acad Neurol. 2015 Oct-Dec;18(4):459-63. doi: 10.4103/0972-2327.165482.

19.

Stem cell transplantation in multiple sclerosis: safety and ethics.

Silani V, Cova L.

J Neurol Sci. 2008 Feb 15;265(1-2):116-21. Epub 2007 Jul 9. Review.

PMID:
17619025
20.

Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis.

Xu J, Ji BX, Su L, Dong HQ, Sun XJ, Liu CY.

Chin Med J (Engl). 2006 Nov 20;119(22):1851-5.

PMID:
17134581
Items per page

Supplemental Content

Write to the Help Desk